Financhill
Back

Intellia Therapeutics Stock Predictions

Intellia Therapeutics Stock Forecast

  • Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 61.6% based on the past 8 years of stock performance.
  • Intellia Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Intellia Therapeutics Stock Undervalued?
    The current Intellia Therapeutics [NTLA] share price is $22.55. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Intellia Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 61.6% based on the past 8 years of stock performance.

Intellia Therapeutics Stock Rating

Sell
29
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics overpriced?

  • Intellia Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Intellia Therapeutics Stock Price History

Is NTLA stock going to rise?

  • The current trend is relatively stagnant and NTLA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com

52-Week Data

52-Week High:
34.94
52-Week Low:
19.21

Prediction Charts

Market Cap:
2.29B
Price in USD:
22.55
Volume:
1.46M
Beta:
2.00

Technical Analysis

SMA50:
23.38
SMA100:
23.56
SMA200:
25.58
52-Wk Change:
-37.05%

Stock Predictions

  • Is Intellia Therapeutics stock public?
    Yes, Intellia Therapeutics is a publicly traded company.
  • What is the Intellia Therapeutics stock quote today?
    The Intellia Therapeutics stock price is 22.55 USD today.
  • How to buy Intellia Therapeutics stock online?
    You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-28 22.83 22.35 23.02 22.09
Aug-29 22.49 23.00 23.50 22.34
Aug-30 23.06 22.44 23.19 21.93
Sep-3 22.35 21.61 23.09 21.51
Sep-4 21.72 21.27 22.15 21.07
Sep-5 21.24 20.94 21.56 20.72
Sep-6 21.00 19.72 21.33 19.51
Sep-9 19.85 19.83 20.14 19.52
Sep-10 19.86 20.12 20.38 19.31
Sep-11 19.79 20.24 20.29 19.21
Sep-12 20.20 20.67 20.68 19.61
Sep-13 21.14 22.07 22.22 21.00
Sep-16 22.11 21.51 22.22 21.21
Sep-17 21.81 22.55 23.15 21.77

Intellia Therapeutics Earnings

Intellia Therapeutics Earnings Report: Per Share Intellia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intellia Therapeutics Forecast Revenue Growth

Intellia Therapeutics Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.20 per share.

* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.